FTC Releases Second Interim Staff Report on Prescription Drug …
3 days ago · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty generic drugs, including significant price markups by PBMs for cancer, HIV, and a variety of other critical drugs.
Pharmacy Benefit Managers: The Powerful Middlemen Inflating …
Jul 9, 2024 · Report on Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies (2.47 MB)
Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC …
The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
Jul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug...
PBMs made billions marking up specialty drugs by more than …
2 days ago · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...
FTC releases second report slamming pharmacy benefit managers
3 days ago · The FTC has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S. RiverNorthPhotography via Getty Images
Second Federal Trade Commission Report on Pharmacy Benefit Managers ...
2 days ago · The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers” as part of an ongoing study examining the practices of Pharmacy Benefit Managers (PBMs) within the U.S. healthcare system. This report highlights significant concerns about the pricing strategies of PBMs concerning ...
Pharmacy benefit managers profit at expense of patients and small ... - CNN
Jul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
US FTC Finds Major Pharmacy Benefit Managers Inflated Drug …
3 days ago · US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain ... -The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain ...
- Some results have been removed